This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: BHI GNC LO SBGI STZ

Stocks in this article: BHI GNC LO SBGI STZ

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Baker Hughes (BHI) was upgraded at Goldman Sachs to buy from neutral. Twelve-month price target is $72. Company should benefit from an improving pressure pumping market, Goldman said.

Bellatrix Exploration (BXE) was downgraded to sell at TheStreet Ratings.

Commvault (CVLT) was upgraded at Mizuho to buy from neutral. Twelve-month price target is $80. Company can continue to gain market share, Mizuho said.

Ever-Glory International (EVK) was upgraded to buy at TheStreet Ratings.

Facebook (FB) was downgraded at Argus to hold from buy. Valuation call, Argus said.

FEI (FEIC) was downgraded at DA Davidson to neutral from buy. Valuation call, based on a 12-month price target of $105.

GNC (GNC) was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $51. Company has lower sales visibility, Credit Suisse said.

Lorillard (LO) was upgraded at Goldman Sachs to buy. Company is attractive, based on a sum-of-the-parts valuation, Goldman Sachs said.

Martin Midstream Partners (MMLP) was upgraded at UBS to buy from neutral. Alinda Capital Partners acquisition LT positive, UBS said. Twelve-month price target is $46. Buy rating.

Netscout (NTCT) was downgraded at DA Davidson to neutral from buy. Valuation call, as the stock is up 35% year to date, DA Davidson said. Twelve-month price target is $40.

Patterson-UTI (PTEN) was upgraded at Goldman Sachs to buy from neutral. Company was also placed on the Conviction List, Goldman said. Twelve-month price target is $37. Expect higher onshore pricing in North America, Goldman said.

Regeneron (REGN) was upgraded at Citigroup to buy. See a lot of value embedded in the clinical pipeline, Citigroup said.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs